돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 324679생성일: 2026년 10월 23일

Boron trifluoride etherate → 4-Pentenal diethyl acetal

https://huagongshe.com/ko/reaction/324679

반응식

참여 물질

역할이름HCID투입량
반응물Boron trifluoride etherateHCID 8000—
반응물4-PentenalHCID 16418—
반응물DoxorubicinHCID 31703—
용매EthanolHCID 702—
생성물4-Pentenal diethyl acetalHCID 10630780—

반응 단계

Boron trifluoride diethyl etherate (0.2 mL) was added, with stirring, to a solution of 4-pentenal (Cherif, A.; Farquhar, D. N-(5,5-diacetoxypent-1-yl)doxorubicin: A new intensely potent doxorubicin analogue. J. Med. Chem. 35, 3208-3214 (1992)) (2.5 g, 29.8 mmol) in ethanol (150 mL). The mixture was refluxed for 10 min under nitrogen, then the ethanol was removed under reduced pressure. The residue was taken up in dichloromethane (25 mL), and the solution was washed with 10% sodium acetate solution (15 mL) and water (2×10 mL). The organic layers were combined, dried over anhydrous sodium sulfate, and evaporated. The residue was chromatographed on a column of silica gel using chloroform/methanol (97:3) as eluent. 4-Pentenal diethyl acetal was obtained as an oil (4.5 g, 96%). 1H NMR (CDCl3) δ 5.88-5.61 (m, 1 H, H4), 5.03-4.87 (m, 2 H, H5), 4.38 (t, 1 H, J=7, H1), 3.30-3.61(m, 4 H, 2×CH2), 2.07-1.96 (m, 2 H, H2), 1.64-1.53 (m, 2 H, H3), 1.09 (t, 6 H, J=7, 2×CH3).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06218519B1
출처 데이터셋uspto-grants-2001_04
ORD IDord-d93eb0a365844c8d9b062230673c7ea9
출처 메모uspto-grants-2001_04